Biolargo, Inc. (BLGO) Stock Forecast Oct. 16, 2026
Analysis updated on Oct. 16, 2026 (UTC) · Total · absolute moveSwitch to Alpha · OTC
Biolargo, Inc. (BLGO) stock forecast summary
Our AI ranks Biolargo, Inc. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
Biolargo, Inc. is a small-cap company with a market capitalization of $23M. It ranks number 15 by market capitalization among the 17 Chemicals & Allied Products issuers in our coverage with a current forecast.
For BLGO, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 8.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 11.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected absolute price move over the horizon, market included. This is the number a price target is built from. Ratings: strong buy ≥ +5.1%, buy ≥ +3.4%, sell < +1.8%, strong sell < +0.8% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-16 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, BLGO included.
Follow BLGO freeBLGO price chart and AI forecast
How BLGO ranks among 5184 stocks
90D Total forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Biolargo, Inc. (BLGO) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Chemicals & Allied Products peers listed below that report each metric.
Valuation & Market
| Metric | BLGO | Rank |
|---|---|---|
| Market Cap | $23M | 15/17 |
| Revenue/Share | $0.01 | – |
Profitability & Margins
| Metric | BLGO | Rank |
|---|---|---|
| ROA | -234.7% | 12/13 |
| Gross Margin | 45.3% | 3/14 |
| Operating Margin | -504.1% | 11/13 |
| Net Margin | -435.5% | 11/12 |
| EBT Margin | -513.8% | 13/14 |
| Tax Rate | 0.0% | – |
Financial Health
| Metric | BLGO | Rank |
|---|---|---|
| Current Ratio | 0.73x | 15/16 |
| Quick Ratio | 0.67x | 13/13 |
| Interest Coverage | -13.1x | 9/14 |
| Working Capital | -$1M | 15/16 |
Cash Flow
| Metric | BLGO | Rank |
|---|---|---|
| Operating Cash Flow | -$13M | 15/15 |
Operational Efficiency
| Metric | BLGO | Rank |
|---|---|---|
| Asset Turnover | 0.61x | 7/13 |
| Receivables Turnover | 5.6x | 6/10 |
| Inventory Turnover | 8.1x | 3/13 |
| Fixed Assets Turnover | 2.3x | 8/13 |
| Days Sales Outstanding | 65 days | 5/10 |
| Days Inventory | 45 days | 11/13 |
| Payables Period | 130 days | 2/10 |
| Cash Conversion Cycle | -20 days | 6/7 |
Income Statement
| Metric | BLGO | Rank |
|---|---|---|
| Total Revenue | $4M | 10/13 |
| Operating Income | -$18M | 9/14 |
| Net Income | -$16M | 6/13 |
| R&D Expense | $3M | 8/10 |
| SG&A Expense | $13M | 11/13 |
| Cost of Goods Sold | $2M | 12/14 |
Dividend & Shareholder Information
| Metric | BLGO | Rank |
|---|---|---|
| Shares Outstanding | 329M | – |
Balance Sheet Highlights (USD millions)
| Total Current Assets | $4M | |
| Cash & Short-term Investments | $2M | |
| Accounts Receivable | $720K | |
| Inventory | $300K | |
| Total Liabilities | $9M | |
| Short-term Debt | $4M |
BLGO quarterly financials and insider trading
Biolargo, Inc. (BLGO) industry peers
Companies classified under the same SEC industry code as Biolargo, Inc. (Chemicals & Allied Products): 17 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Total) | Market Cap |
|---|---|---|
| BLGO Biolargo, Inc. | ▲ | $23M |
| BCPC Balchem Corp | ▼ | $5.44B |
| PRM Perimeter Solutions, Inc. | ▶ | $4.34B |
| NGVT Ingevity Corp | ▶ | $2.40B |
| IOSP Innospec Inc. | ▼ | $2.38B |
| CC Chemours Co | ▶ | $1.92B |
| OLN Olin Corp | ▼ | $1.78B |
| HUN Huntsman Corp | ▶ | $1.49B |
| ECVT Ecovyst Inc. | ▼ | $1.13B |
| FMC Fmc Corp | ▲ | $709M |
| SLI Standard Lithium Ltd. | ▲ | $359M |
| ADUR Aduro Clean Technologies Inc. | ▲ | $330M |
| ACNT Ascent Industries Co. | ▼ | $122M |
| LQMT Liquidmetal Technologies Inc | ▼ | $71M |
| CITR Citrotech Inc. | ▶ | $62M |
| LOOP Loop Industries, Inc. | ▶ | $16M |
| GURE Gulf Resources, Inc. | ▶ | $6M |
Where BLGO sits on the market map
Biolargo, Inc. (BLGO) stock news
Loading...
Biolargo, Inc. (BLGO) stock forecast FAQ
What is the Biolargo, Inc. (BLGO) stock forecast?
Our AI ranks Biolargo, Inc. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
How accurate are Biolargo, Inc. stock predictions?
For BLGO, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 8.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 11.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Biolargo, Inc. forecasts updated?
Biolargo, Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 16, 2026.
Which companies are Biolargo, Inc.'s industry peers?
17 issuers in our coverage, BLGO included, share the SEC industry code Chemicals & Allied Products. The largest are: Balchem Corp (BCPC), Perimeter Solutions, Inc. (PRM), Ingevity Corp (NGVT), Innospec Inc. (IOSP), Chemours Co (CC), Olin Corp (OLN).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.